Terry Chow
Keine laufenden Positionen mehr
Karriereverlauf von Terry Chow
Ehemalige bekannte Positionen von Terry Chow
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| University of Sherbrooke | Corporate Officer/Principal | 01.01.1993 | 01.01.1993 |
National Research Council of Canada
 National Research Council of Canada Miscellaneous Commercial ServicesCommercial Services National Research Council of Canada, provides research & development. It services include research programs and collaboration opportunities, technical and advisory services, licensing opportunities and industrial research assistance program. The company was founded by Graham W. Burton and is headquartered in Ottawa, ON. | Corporate Officer/Principal | 01.01.1986 | - |
Verlyx Pharma, Inc.
 Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1999 | - |
| Gründer | 01.01.1999 | - |
Ausbildung von Terry Chow
| McGill University | Doctorate Degree |
Statistik
International
| Kanada | 5 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Verlyx Pharma, Inc.
Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Health Technology |
National Research Council of Canada
National Research Council of Canada Miscellaneous Commercial ServicesCommercial Services National Research Council of Canada, provides research & development. It services include research programs and collaboration opportunities, technical and advisory services, licensing opportunities and industrial research assistance program. The company was founded by Graham W. Burton and is headquartered in Ottawa, ON. | Commercial Services |
- Börse
- Insiders
- Terry Chow
- Erfahrung